Literature DB >> 22300429

LF immunomodulatory strategies: mastering bacterial endotoxin.

Daniela Latorre1, Francesca Berlutti, Piera Valenti, Sandra Gessani, Patrizia Puddu.   

Abstract

Lactoferrin (LF), an iron-binding glycoprotein expressed in most biological fluids, represents a major component of mammalian innate immune system. The multiple activities of LF rely not only on its capacity to bind iron but also to interact with molecular and cellular components of both the host and pathogens. LF can bind and sequester lipopolysaccharide thus preventing proinflammatory pathway activation, sepsis, and tissue damage. However, the interplay between LF and lipopolysaccharide is complex and may lead to different outcomes including both the suppression of inflammatory response and immune activation. Understanding the molecular basis and the functional consequences of this complex interaction is critically relevant in the development of LF-based therapeutic interventions in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22300429     DOI: 10.1139/o11-059

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  13 in total

1.  Development of dairy herd of transgenic goats as biofactory for large-scale production of biologically active recombinant human lactoferrin.

Authors:  I Semak; A Budzevich; E Maliushkova; V Kuzniatsova; N Popkov; I Zalutsky; O Ivashkevich
Journal:  Transgenic Res       Date:  2019-08-08       Impact factor: 2.788

2.  Lactoferrin and oral diseases: current status and perspective in periodontitis.

Authors:  Francesca Berlutti; Andrea Pilloni; Miriam Pietropaoli; Antonella Polimeni; Piera Valenti
Journal:  Ann Stomatol (Roma)       Date:  2012-01-27

3.  The Effects of Recombinant Human Lactoferrin on Immune Activation and the Intestinal Microbiome Among Persons Living with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy.

Authors:  Ornella Sortino; Kathy Huppler Hullsiek; Elizabeth Richards; Adam Rupert; Andrea Schminke; Namo Tetekpor; Mariam Quinones; Rachel Prosser; Tim Schacker; Irini Sereti; Jason V Baker
Journal:  J Infect Dis       Date:  2019-05-24       Impact factor: 5.226

4.  Modulation of TDM-induced granuloma pathology by human lactoferrin: a persistent effect in mice.

Authors:  Jeffrey K Actor; Thao K T Nguyen; Agnieszka Wasik-Smietana; Marian L Kruzel
Journal:  Biometals       Date:  2022-08-17       Impact factor: 3.378

Review 5.  Lactoferrin: A Modulator for Immunity against Tuberculosis Related Granulomatous Pathology.

Authors:  Jeffrey K Actor
Journal:  Mediators Inflamm       Date:  2015-12-14       Impact factor: 4.711

6.  Bovine Lactoferrin-Induced CCL1 Expression Involves Distinct Receptors in Monocyte-Derived Dendritic Cells and Their Monocyte Precursors.

Authors:  Daniela Latorre; Nadia Pulvirenti; Daniela Angela Covino; Barbara Varano; Cristina Purificato; Gabriella Rainaldi; Maria Cristina Gauzzi; Laura Fantuzzi; Lucia Conti; Gloria Donninelli; Manuela Del Cornò; Michela Sabbatucci; Sandra Gessani; Patrizia Puddu
Journal:  Toxins (Basel)       Date:  2015-12-17       Impact factor: 4.546

7.  Plasma Lactoferrin Levels Positively Correlate with Insulin Resistance despite an Inverse Association with Total Adiposity in Lean and Severely Obese Patients.

Authors:  Sylvain Mayeur; Alain Veilleux; Yves Pouliot; Benoît Lamarche; Jean-François Beaulieu; Frédéric S Hould; Denis Richard; André Tchernof; Emile Levy
Journal:  PLoS One       Date:  2016-11-30       Impact factor: 3.240

Review 8.  Lactoferrin: A Natural Glycoprotein Involved in Iron and Inflammatory Homeostasis.

Authors:  Luigi Rosa; Antimo Cutone; Maria Stefania Lepanto; Rosalba Paesano; Piera Valenti
Journal:  Int J Mol Sci       Date:  2017-09-15       Impact factor: 5.923

9.  Cervico-vaginal mucus (CVM) - an accessible source of immunologically informative biomolecules.

Authors:  Mounir Adnane; Kieran G Meade; Cliona O'Farrelly
Journal:  Vet Res Commun       Date:  2018-08-16       Impact factor: 2.459

10.  Hypothesis: apo-lactoferrin-Galantamine Proteo-alkaloid Conjugate for Alzheimer's disease Intervention.

Authors:  Olufemi D Akilo; Pradeep Kumar; Yahya E Choonara; Priyamvada Pradeep; Lisa C du Toit; Viness Pillay
Journal:  J Cell Mol Med       Date:  2018-01-29       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.